HomeGTBP • NASDAQ
add
GT Biopharma Inc
Previous close
$0.47
Day range
$0.43 - $0.47
Year range
$0.40 - $3.85
Market cap
15.13M USD
Avg Volume
1.19M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.60M | 48.68% |
Net income | -23.03M | -510.09% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.81M | 72.39% |
Total assets | 8.11M | 91.54% |
Total liabilities | 2.32M | -60.71% |
Total equity | 5.79M | — |
Shares outstanding | 31.55M | — |
Price to book | 2.04 | — |
Return on assets | -225.11% | — |
Return on capital | -318.37% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -23.03M | -510.09% |
Cash from operations | -4.02M | -62.93% |
Cash from investing | — | — |
Cash from financing | 8.30M | — |
Net change in cash | 4.28M | 273.65% |
Free cash flow | -2.47M | -136.26% |
About
Founded
1965
Headquarters
Website
Employees
1
